An experienced biotechnology entrepreneur and the former Chief Executive Officer of Avalanche Biotechnologies, Inc., Thomas Chalberg has earned recognition as a biotechnology thought leader in Silicon Valley. Tom Chalberg co-founded Avalanche Biotechnologies, a gene therapy R&D company for ophthalmic conditions. He joined Avalanche as its first employee, and as CEO grew the company to more than 75 employees.
As a technical expert in the gene therapy field, Thomas Chalberg is an author on a number of peer-reviewed publications in top journals, including The Lancet and Nature Biotechnology, and has served as Principal Investigator for a National Institutes of Health Small Business Innovatio